ÂÜÀòÂÒÂ×

David Greb is a seasoned professional with extensive experience in the medical and pharmaceutical industries, currently serving as Head of Medical Product & Channel Strategy at Canopy Growth Corporation's Spectrum Therapeutics since September 2017. Greb has been instrumental in establishing B2B distribution channels and partnerships, overseeing medical product development, and spearheading educational initiatives aimed at enhancing industry growth. Previous roles include leadership positions at Rexall Pharmacy Group and LifeLabs Medical Laboratory Services, where noteworthy accomplishments include leading national account management teams and significantly increasing revenue. With degrees in Biomedical Toxicology and Economics from the University of Guelph, along with advanced certifications from various institutions, Greb combines academic prowess with practical expertise in commercialization strategy and market access.